STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

ENLV ENLIVEX THERAPEUTICS LIMITED StockScouter® Report

4

StockScouter® Score

ENLIVEX THERAPEUTICS LIMITED, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Moving average analysis for ENLV suggests strong price movement over the medium term. Positive
  • The multi-period measure of relative price change and consistency is above average. Positive/Neutral

 

Concerns

  • Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
  • Shares are being sold by financial institutions. Slightly negative for a small company like ENLV

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

D
C
N/A
B

Previous Ratings

2
2
7